140 related articles for article (PubMed ID: 23504608)
1. Plasminogen-plasmin system in the pathogenesis and treatment of lung and pleural injury.
Tucker T; Idell S
Semin Thromb Hemost; 2013 Jun; 39(4):373-81. PubMed ID: 23504608
[TBL] [Abstract][Full Text] [Related]
2. Coagulation, fibrinolysis, and fibrin deposition in acute lung injury.
Idell S
Crit Care Med; 2003 Apr; 31(4 Suppl):S213-20. PubMed ID: 12682443
[TBL] [Abstract][Full Text] [Related]
3. The Contribution of the Urokinase Plasminogen Activator and the Urokinase Receptor to Pleural and Parenchymal Lung Injury and Repair: A Narrative Review.
Tucker TA; Idell S
Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33535429
[TBL] [Abstract][Full Text] [Related]
4. Abnormalities of pathways of fibrin turnover in the human pleural space.
Idell S; Girard W; Koenig KB; McLarty J; Fair DS
Am Rev Respir Dis; 1991 Jul; 144(1):187-94. PubMed ID: 2064128
[TBL] [Abstract][Full Text] [Related]
5. Dose dependency of outcomes of intrapleural fibrinolytic therapy in new rabbit empyema models.
Komissarov AA; Florova G; Azghani AO; Buchanan A; Boren J; Allen T; Rahman NM; Koenig K; Chamiso M; Karandashova S; Henry J; Idell S
Am J Physiol Lung Cell Mol Physiol; 2016 Aug; 311(2):L389-99. PubMed ID: 27343192
[TBL] [Abstract][Full Text] [Related]
6. Effects of intrapleural heparin or urokinase on the extent of tetracycline-induced pleural disease.
Strange C; Baumann MH; Sahn SA; Idell S
Am J Respir Crit Care Med; 1995 Feb; 151(2 Pt 1):508-15. PubMed ID: 7842213
[TBL] [Abstract][Full Text] [Related]
7. Pathways of fibrin turnover of human pleural mesothelial cells in vitro.
Idell S; Zwieb C; Kumar A; Koenig KB; Johnson AR
Am J Respir Cell Mol Biol; 1992 Oct; 7(4):414-26. PubMed ID: 1389210
[TBL] [Abstract][Full Text] [Related]
8. Update on Novel Targeted Therapy for Pleural Organization and Fibrosis.
Tucker TA; Idell S
Int J Mol Sci; 2022 Jan; 23(3):. PubMed ID: 35163509
[TBL] [Abstract][Full Text] [Related]
9. Association between inflammatory mediators and the fibrinolysis system in infectious pleural effusions.
Alemán C; Alegre J; Monasterio J; Segura RM; Armadans L; Anglés A; Varela E; Ruiz E; Fernández de Sevilla T
Clin Sci (Lond); 2003 Nov; 105(5):601-7. PubMed ID: 12826021
[TBL] [Abstract][Full Text] [Related]
10. [Current value of intrapleural fibrinolysis in the treatment of exudative fibrinous pleural effusions in pleural empyema and hemothorax].
Kemper P; Köhler D
Pneumologie; 1999 Aug; 53(8):373-84. PubMed ID: 10483276
[TBL] [Abstract][Full Text] [Related]
11. Plasminogen activator inhibitor-1 deficiency augments visceral mesothelial organization, intrapleural coagulation, and lung restriction in mice with carbon black/bleomycin-induced pleural injury.
Tucker TA; Jeffers A; Alvarez A; Owens S; Koenig K; Quaid B; Komissarov AA; Florova G; Kothari H; Pendurthi U; Mohan Rao LV; Idell S
Am J Respir Cell Mol Biol; 2014 Feb; 50(2):316-27. PubMed ID: 24024554
[TBL] [Abstract][Full Text] [Related]
12. Thrombin-thrombomodulin inhibits prourokinase-mediated pleural mesothelial cell-dependent fibrinolysis.
Iakhiaev AV; Nalian A; Koenig K; Idell S
Thromb Res; 2007; 120(5):715-25. PubMed ID: 17275887
[TBL] [Abstract][Full Text] [Related]
13. Relationships among tumor burden, tumor size, and the changing concentrations of fibrin degradation products and fibrinolytic factors in the pleural effusions of rabbits with VX2 lung tumors.
Hatton MW; Southward SM; Ross BL; Clarke BJ; Singh G; Richardson M
J Lab Clin Med; 2006 Jan; 147(1):27-35. PubMed ID: 16443002
[TBL] [Abstract][Full Text] [Related]
14. Intrapleural adenoviral delivery of human plasminogen activator inhibitor-1 exacerbates tetracycline-induced pleural injury in rabbits.
Karandashova S; Florova G; Azghani AO; Komissarov AA; Koenig K; Tucker TA; Allen TC; Stewart K; Tvinnereim A; Idell S
Am J Respir Cell Mol Biol; 2013 Jan; 48(1):44-52. PubMed ID: 23002099
[TBL] [Abstract][Full Text] [Related]
15. Precision-guided, Personalized Intrapleural Fibrinolytic Therapy for Empyema and Complicated Parapneumonic Pleural Effusions: The Case for the Fibrinolytic Potential.
Idell S; Florova G; Shetty S; Tucker T; Idell R; Koenig K; Azghani A; Rahman NM; Komissarov A
Clin Pulm Med; 2017 Jul; 24(4):163-169. PubMed ID: 29081644
[TBL] [Abstract][Full Text] [Related]
16. Pleural fibrinolytic activity is decreased in inflammation as demonstrated in quinacrine pleurodesis treatment of malignant pleural effusion.
Agrenius V; Chmielewska J; Widström O; Blombäck M
Am Rev Respir Dis; 1989 Nov; 140(5):1381-5. PubMed ID: 2817601
[TBL] [Abstract][Full Text] [Related]
17. Intrapleural activation, processing, efficacy, and duration of protection of single-chain urokinase in evolving tetracycline-induced pleural injury in rabbits.
Idell S; Allen T; Chen S; Koenig K; Mazar A; Azghani A
Am J Physiol Lung Cell Mol Physiol; 2007 Jan; 292(1):L25-32. PubMed ID: 16980376
[TBL] [Abstract][Full Text] [Related]
18. Single-chain urokinase in empyema induced by Pasturella multocida.
Idell S; Jun Na M; Liao H; Gazar AE; Drake W; Lane KB; Koenig K; Komissarov A; Tucker T; Light RW
Exp Lung Res; 2009 Oct; 35(8):665-81. PubMed ID: 19895321
[TBL] [Abstract][Full Text] [Related]
19. Fibrinolysis--a review.
Kane KK
Ann Clin Lab Sci; 1984; 14(6):443-9. PubMed ID: 6239587
[TBL] [Abstract][Full Text] [Related]
20. From fibrinolysis to the plasminogen-plasmin system and beyond: a remarkable growth of knowledge, with personal observations on the history of fibrinolysis.
Kwaan HC
Semin Thromb Hemost; 2014 Jul; 40(5):585-91. PubMed ID: 25000957
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
